Search Results

Fraser Health Patient Education Materials

Results 1 of 2 for search: *:*
  • Substance Use: buprenorphine-naloxone (Suboxone) and Opioid Agonist Treatment Clinics (Fraser Health) [English] Public

    This is a document that has been adapted from the one that is currently with the buprenorphine/naloxone induction package. Minor changes have been made but this one should be with the take home suboxone information, as there have been some edits to the opening box that would only apply to take home suboxone and not a hospital induction. (English) Colour

    Printing Cost:
    $0.03 (B&W) $0.18 (Colour)
    Packaging Unit Quantity:
    50
    Printshop Number:
    265745
    Body Location:
    • Brain and Nervous System
    Diagnosis and Therapy:
    • Rehabilitation and Recovery,
    • Drug, Fluid and Nutrition Therapy
    Disorders and Conditions:
    • Substance Use
    Keywords:
    • Withdrawal,
    • Treatment,
    • Therapy,
    • Drug,
    • Addiction,
    • Overdose,
    • Narcotic,
    • Opioid,
    • Naloxone,
    • OAT,
    • Agonist,
    • Street,
    • Rapid,
    • Access,
    • Creekside
    MESH:
    • Substance Abuse
    Demographic:
    • All
    Site:
    • Fraser Health
    Program:
    • Emergency,
    • Mental Health and Substance Use
    Professional or Practice Group:
    • Nursing
    Format:
    Factsheet
    Paper Size:
    8.5 x 11 Letter
    Paper Colour:
    White
    Title Page Paper Colour:
    White
    Folding:
    No fold
    Plain Language:
    True
    Reproduction Rights:
    Adapted ‘Opioid agonist therapy’ (2016) with permission from the Centre for Addiction and Mental Health (www.camh.ca)
    Record Type:
    FHA
    Revision Date:
    May 28, 2021
    Next Revision Date:
    May 28, 2024
    Record Created:
    January 31, 2018
    Record Modified:
    May 28, 2021
    Packaging Unit Quantity:
    50
    Impressions:
    1

Narrow Search